Cellid, Inc.
http://www.cellid.co.kr/?lang=en
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cellid, Inc.
Korea Kick-Starts Major Consortium For Next-Gen mRNA Vaccines
Bookmark
-
Analysis
South Korea is stepping on the gas to develop its own mRNA COVID-19 vaccine and eventually next generation mRNA platform technology for use in other diseases, to meet its goal of becoming a global vaccine hub.
Coronavirus Update: EU Demands AstraZeneca Meets Its Vaccines Commitments After Supply Warning
Bookmark
-
News
Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
Advertisement
Advertisement